Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update.

Authors:
Bellal M; Malherbe J; Damaj G; Du Cheyron D.

Journal:
Crit Care

Publication Year: 2024

DOI:
10.1186/s13054-024-04851-0

PMCID:
PMC10916319

PMID:
38444031

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Crit Care

Abbreviation: Crit Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accuracy of respiratory muscle assessments to predict weaning outcomes: a systematic review and com…
Poddighe D; Van Hollebeke M; Choudhary YQ and 6 more (2024) - Transparency Score: 4/6
Administration of methylene blue in septic shock: pros and cons.
Arias-Ortiz J; Vincent JL. (2024) - Transparency Score: 3/6
Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterob…
Petit M; Bidar F; Fosse Q and 19 more (2024) - Transparency Score: 4/6
Coexistence of a fluid responsive state and venous congestion signals in critically ill patients: a…
Muñoz F; Born P; Bruna M and 15 more (2024) - Transparency Score: 3/6
Driving pressure of respiratory system and lung stress in mechanically ventilated patients with act…
Stamatopoulou V; Akoumianaki E; Vaporidi K and 3 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This review did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025